| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 6e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-07 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |